Elanco Animal Health Incorporated
DE ˙ DB ˙ US28414H1032
20,80 € ↑0,04 (0,19%)
2026-06-05
CENA AKCJI
SecurityDE:5EA / Elanco Animal Health Incorporated
InstitutionJupiter Asset Management Ltd
Latest Disclosed Ownership3,110,039 shares
Latest Disclosed Value $ 74,423,233
Jupiter Asset Management Ltd reports 14.41% decrease in ownership of 5EA / Elanco Animal Health Incorporated

On May 12, 2026 - Jupiter Asset Management Ltd filed a 13F-HR form disclosing ownership of 3,110,039 shares of Elanco Animal Health Incorporated (DE:5EA) valued at $63,429,245 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 3,633,794 shares of Elanco Animal Health Incorporated. This represents a change in shares of -14.41% during the quarter. The current value of the position is $64,688,811 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ELANCO ANIMAL HEALTH COM* 28414H103 3,110,039 -523,755 -14.41 74,423 -9.50 0.3135
2026-02-10 2025-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 3,633,794 -83,055 -2.23 82,233 9.85 0.6582
2025-11-10 2025-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 3,716,849 1,846,907 98.77 74,857 180.34 0.6426
2025-08-08 2025-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,869,942 233,163 14.25 26,703 55.37 0.2228
2025-05-09 2025-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,636,779 262,315 19.08 17,186 3.26 0.1647
2025-02-10 2024-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,374,464 849,977 162.06 16,645 116.04 0.1623
2024-11-12 2024-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 524,487 180,495 52.47 7,705 55.23 0.0675
2024-08-08 2024-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 343,992 39,548 12.99 4,964 0.14 0.0469
2024-05-10 2024-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 304,444 304,444 4,956 0.0473
2022-11-10 2022-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 0 -146,398 -100.00 0 -100.00
2022-08-10 2022-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 146,398 146,398 2,872 0.0404
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.